PowerPoint slides Rights and permissions About this article Cite this article Picardo, M., Dell'Anna, M., Ezzedine, K
N Engl J Med (2016) 375(4):31122
Baseline and periodic measurement of vitamins A, D, E, and K may be warranted in patients with documented malabsorption
However, further research is necessary to elucidate the underlying molecular mechanisms and validate the efficacy of NAC in clinical settings
SS-31 (elamipretide) , a mitochondria-targeted peptide that stabilizes cardiolipin to support energy production, became the first FDA-approved mitochondrial therapeutic in 2025, though only for the rare Barth syndrome, with the brain rationale still mechanistic and no cognitive trials
doi: 10.1128/AAC.04005-14 181 QuJ.LesseA